JD

Change Requests

Submit and track change requests across the organization.

Total CRs

8

Pending Review

5

Approved

2

Rejected

0

CR IDTitleSourceStatusCreated
CR-BFE071CA

Post-market complaint: HA-1000 display flicker

Complaint from Karolinska University Hospital: 2 HA-1000 units exhibit intermittent display flickering after 18 months of continuous operation. Suspected power supply capacitor aging.

CLAIM
SUBMITTED
3/10/2026
CR-17C09E6B

Migrate cloud infrastructure to GDPR-compliant EU data center

Current US-based cloud hosting does not meet GDPR requirements for patient diagnostic data. Evaluate Azure West Europe and AWS eu-central-1 options.

INTERNAL
SUBMITTED
3/10/2026
CR-C12EE15B

Add Spanish and Portuguese language to IFU

Market expansion into LATAM region requires multilingual Instructions for Use. Translation validation required per SOP-DMS-001.

MARKET
DRAFT
3/10/2026
CR-37DF60A5

Transition to IVDR-compliant labeling

All IVD labels must comply with IVDR Annex I, Section 20 by May 2027. Project scope: 47 product labels, 12 IFUs, 3 outer packaging designs.

RISK
SUBMITTED
3/10/2026
CR-29F6F1F5

Upgrade HA-1000 firmware to v4.2

Firmware update includes: improved calibration algorithm, cybersecurity patches (IEC 81001-5-1), and data export format alignment with HL7 FHIR standards.

INTERNAL
REVIEW
3/10/2026
CR-39932CE4

CAPA #IVD-2025-031: False positive rate deviation

Trend analysis detected 0.8% false positive rate increase in Lot 2026-R045. Root cause: antibody conjugation process temperature drift. Immediate containment: quarantine remaining lot inventory.

CAPA
SUBMITTED
3/10/2026
CR-56A0B2EC

Reagent shelf life extension study

Accelerated stability data suggests potential 6-month shelf life extension for RGT-500 reagent cartridges. Requires real-time stability confirmation and IFU update.

MARKET
APPROVED
3/10/2026
CR-36A42325

IVDR Class C reclassification impact assessment

EU IVDR reclassification: RGT-500 test kits now classified as Class C (previously self-declared). Requires notified body involvement and updated technical documentation.

RISK
APPROVED
3/10/2026